Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Boyton, Rosemary"" wg kryterium: Autor


Tytuł:
Reciprocal conditioning: T cells as regulators of dendritic cell function.
Autorzy:
Altmann DM; Human Disease Immunogenetics Group, Department of Infectious Diseases, Imperial College London, Hammersmith Hospital, London, UK. />Boyton RJ
Pokaż więcej
Źródło:
Immunology [Immunology] 2003 Aug; Vol. 109 (4), pp. 473-5.
Typ publikacji:
Journal Article
MeSH Terms:
Dendritic Cells/*immunology
T-Lymphocytes/*immunology
Antigen-Presenting Cells/immunology ; CD8-Positive T-Lymphocytes/immunology ; Cytokines/immunology ; Humans ; Immunity, Innate/immunology ; Lymphocyte Activation/immunology ; T-Lymphocytes, Helper-Inducer/immunology
Czasopismo naukowe
Tytuł:
Increased HLA-E expression in white matter lesions in multiple sclerosis.
Autorzy:
Durrenberger PF; Department of Medicine, Section of Infectious Diseases and Immunity, Hammersmith Hospital, Imperial College, London, UK.
Webb LV
Sim MJ
Nicholas RS
Altmann DM
Boyton RJ
Pokaż więcej
Źródło:
Immunology [Immunology] 2012 Dec; Vol. 137 (4), pp. 317-25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Brain/*metabolism
Histocompatibility Antigens Class I/*biosynthesis
Multiple Sclerosis/*metabolism
Multiple Sclerosis/*pathology
Adult ; Brain/pathology ; CD8-Positive T-Lymphocytes/physiology ; Female ; Humans ; Killer Cells, Natural/physiology ; Male ; Middle Aged ; NK Cell Lectin-Like Receptor Subfamily C/genetics ; RNA, Messenger/analysis ; RNA, Messenger/genetics ; HLA-E Antigens
Czasopismo naukowe
Tytuł:
Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity.
Autorzy:
Ascough S; Department of Medicine, Imperial College London, London, United Kingdom.
Ingram RJ; Centre for Infection and Immunity, Queen's University Belfast, Belfast, United Kingdom.
Chu KK; Department of Medicine, Imperial College London, London, United Kingdom.
Reynolds CJ; Department of Medicine, Imperial College London, London, United Kingdom.
Musson JA; Institute for Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Doganay M; Department of Infectious Disease, Erciyes University Hospital, Kayseri, Turkey.
Metan G; Department of Infectious Disease, Erciyes University Hospital, Kayseri, Turkey.
Ozkul Y; Department of Medical Genetics, Erciyes University Hospital, Kayseri, Turkey.
Baillie L; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, United Kingdom.
Sriskandan S; Department of Medicine, Imperial College London, London, United Kingdom.
Moore SJ; BIOMET, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Gallagher TB; BIOMET, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Dyson H; Defence Science Technology Laboratory, Porton Down, Salisbury, United Kingdom.
Williamson ED; Defence Science Technology Laboratory, Porton Down, Salisbury, United Kingdom.
Robinson JH; Institute for Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Maillere B; CEA, iBiTecS, Service d'Ingénierie Moléculaire des Protéines (SIMOPRO), Gif Sur Yvette, France.
Boyton RJ; Department of Medicine, Imperial College London, London, United Kingdom.
Altmann DM; Department of Medicine, Imperial College London, London, United Kingdom.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2014 May 01; Vol. 10 (5), pp. e1004085. Date of Electronic Publication: 2014 May 01 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Anthrax Vaccines*/chemistry
Anthrax Vaccines*/therapeutic use
Polymorphism, Genetic*
Anthrax/*prevention & control
Antigens, Bacterial/*immunology
Bacterial Toxins/*immunology
CD4-Positive T-Lymphocytes/*immunology
HLA Antigens/*genetics
Immunity, Cellular/*genetics
Skin Diseases, Bacterial/*prevention & control
Adult ; Amino Acid Sequence ; Animals ; Anthrax/immunology ; Antigens, Bacterial/chemistry ; Bacterial Toxins/chemistry ; Epitope Mapping ; HLA Antigens/immunology ; Humans ; Immunodominant Epitopes/chemistry ; Immunodominant Epitopes/immunology ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Models, Molecular ; Molecular Targeted Therapy ; Skin Diseases, Bacterial/immunology ; Young Adult
SCR Disease Name:
Cutaneous anthrax
Czasopismo naukowe
Tytuł:
The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II alleles.
Autorzy:
Reynolds CJ; Section of Infectious Diseases and Immunity, Department of Medicine, Imperial College, Hammersmith Hospital, London, UK.
Jones C
Blohmke CJ
Darton TC
Goudet A
Sergeant R
Maillere B
Pollard AJ
Altmann DM
Boyton RJ
Pokaż więcej
Źródło:
Immunology [Immunology] 2014 Nov; Vol. 143 (3), pp. 438-46.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigen Presentation/*immunology
Bacterial Proteins/*immunology
CD4 Antigens/*immunology
Histocompatibility Antigens Class II/*immunology
Immunodominant Epitopes/*immunology
Molecular Chaperones/*immunology
Alleles ; Amino Acid Sequence ; Animals ; Bacterial Proteins/chemistry ; CD4-Positive T-Lymphocytes/immunology ; Epitopes, T-Lymphocyte/chemistry ; Epitopes, T-Lymphocyte/immunology ; Genotype ; HLA-DR Antigens/genetics ; HLA-DR Antigens/immunology ; HLA-DR Antigens/metabolism ; Histocompatibility Antigens Class II/genetics ; Humans ; Immunodominant Epitopes/chemistry ; Mice ; Mice, Transgenic ; Molecular Chaperones/chemistry ; Molecular Sequence Data ; Peptide Fragments/chemistry ; Peptide Fragments/immunology ; Protein Binding/immunology ; Sequence Alignment
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies